Literature DB >> 22179200

[Mucinous neoplasms of the vermiform appendix, Pseudomyxoma peritonei, and the new WHO classification].

S Reu1, J Neumann, T Kirchner.   

Abstract

Mucinous neoplasms of the appendix are rare tumors, some of them characterized by an enigmatic discrepancy between a benign morphologic appearance and an aggressive biologic potential, associated with a poor prognosis and high mortality. The clinical picture of pseudomyxoma peritonei is, with few exceptions, caused by mucinous appendiceal neoplasms and differs in many aspects from usual peritoneal carcinomatosis. The controversy regarding terminology, diagnostic criteria, classification and therapy of these tumors has lasted for decades. The revised edition of the World Health Organization Classification of Tumors of the Digestive System proposes a uniform reporting system for mucinous appendiceal neoplasms and the peritoneal disease associated with it, thereby creating a comparable basis for pathological diagnosis, clinical therapy and further scientific studies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22179200     DOI: 10.1007/s00292-011-1542-z

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  20 in total

1.  Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.

Authors:  B M Ronnett; H Yan; R J Kurman; B M Shmookler; L Wu; P H Sugarbaker
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

2.  CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.

Authors:  D Nonaka; S Kusamura; D Baratti; P Casali; R Younan; M Deraco
Journal:  Histopathology       Date:  2006-10       Impact factor: 5.087

Review 3.  Appendiceal mucinous tumors and pseudomyxoma peritonei: histologic features, diagnostic problems, and proposed classification.

Authors:  Reetesh K Pai; Teri A Longacre
Journal:  Adv Anat Pathol       Date:  2005-11       Impact factor: 3.875

4.  Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.

Authors:  Robert F Bradley; John H Stewart; Gregory B Russell; Edward A Levine; Kim R Geisinger
Journal:  Am J Surg Pathol       Date:  2006-05       Impact factor: 6.394

5.  Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin.

Authors:  Haney Youssef; Christopher Newman; Kandiah Chandrakumaran; Faheez Mohamed; Tom D Cecil; Brendan J Moran
Journal:  Dis Colon Rectum       Date:  2011-03       Impact factor: 4.585

6.  Survival of patients with pseudomyxoma peritonei treated by serial debulking.

Authors:  P Järvinen; H J Järvinen; A Lepistö
Journal:  Colorectal Dis       Date:  2009-06-10       Impact factor: 3.788

7.  Defective mismatch repair in the pathogenesis of low-grade appendiceal mucinous neoplasms and adenocarcinomas.

Authors:  Joseph Misdraji; Lawrence J Burgart; Gregory Y Lauwers
Journal:  Mod Pathol       Date:  2004-12       Impact factor: 7.842

8.  Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases.

Authors:  Joseph Misdraji; Rhonda K Yantiss; Fiona M Graeme-Cook; Ulysses J Balis; Robert H Young
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

9.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

Authors:  B M Ronnett; C M Zahn; R J Kurman; M E Kass; P H Sugarbaker; B M Shmookler
Journal:  Am J Surg Pathol       Date:  1995-12       Impact factor: 6.394

10.  Epithelial noncarcinoid tumors and tumor-like lesions of the appendix. A clinicopathologic study of 184 patients with a multivariate analysis of prognostic factors.

Authors:  N J Carr; W F McCarthy; L H Sobin
Journal:  Cancer       Date:  1995-02-01       Impact factor: 6.860

View more
  1 in total

1.  Outcomes Following Cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-Year Experience.

Authors:  Vignesh Narasimhan; Kasmira Wilson; Maneka Britto; Satish Warrier; A Craig Lynch; Michael Michael; Jeanne Tie; Tim Akhurst; Catherine Mitchell; Robert Ramsay; Alexander Heriot
Journal:  J Gastrointest Surg       Date:  2019-05-14       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.